These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 34486081

  • 21. [A Case of Laparoscopic Gastrectomy for Gastric GIST after Neoadjuvant Chemotherapy with Imatinib Mesylate].
    Iwanaga T, Yamamoto S, Tsukamoto Y, Hamaguchi H, Katsumori T, Ohshima H.
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1950-2. PubMed ID: 26805227
    [Abstract] [Full Text] [Related]

  • 22. Solitary peritoneal metastasis of gastrointestinal stromal tumor: A case report.
    Sugiyama Y, Shimbara K, Sasaki M, Kouyama M, Tazaki T, Takahashi S, Nakamitsu A.
    World J Gastroenterol; 2020 Sep 28; 26(36):5527-5533. PubMed ID: 33024403
    [Abstract] [Full Text] [Related]

  • 23. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
    Kang YK, Kang BW, Im SA, Lee JL, Park SR, Kang WK, Chang HM, Kim TW, Oh DY, Jung KH, Ryu MH.
    Cancer Chemother Pharmacol; 2013 Jan 28; 71(1):43-51. PubMed ID: 23053257
    [Abstract] [Full Text] [Related]

  • 24. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor.
    Wu X, Li J, Xu W, Gao J, Li Y, Shen L.
    Future Oncol; 2018 Jul 28; 14(17):1721-1729. PubMed ID: 29969914
    [Abstract] [Full Text] [Related]

  • 25. Long-term survival of a case with multiple liver metastases from duodenal gastrointestinal stromal tumor drastically reduced by the treatment with imatinib and hepatectomy.
    Sakakura C, Hagiwara A, Soga K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yamaoka N, Sagara Y, Yamagishi H.
    World J Gastroenterol; 2006 May 07; 12(17):2793-7. PubMed ID: 16718773
    [Abstract] [Full Text] [Related]

  • 26. Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
    Colović R, Micev M, Matić S, Colović N, Grubor N, Atkinson HD.
    Vojnosanit Pregl; 2013 Feb 07; 70(2):225-8. PubMed ID: 23607193
    [Abstract] [Full Text] [Related]

  • 27. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
    Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Monge OR, Bono P, Kallio R, Vehtari A, Leinonen M, Alvegård T, Reichardt P.
    JAMA; 2012 Mar 28; 307(12):1265-72. PubMed ID: 22453568
    [Abstract] [Full Text] [Related]

  • 28. Is imatinib justified as an adjuvant chemotherapy for patients with recurrent gastrointestinal stromal tumors.
    Lai IR, Hu RH, Chang KJ.
    Hepatogastroenterology; 2005 Mar 28; 52(63):826-8. PubMed ID: 15966213
    [Abstract] [Full Text] [Related]

  • 29. [Long-term survival after surgery and adjuvant imatinib in a patient with rectal GIST, local recurrence, liver metastases and mediastinal pleural metastasis].
    Tsutsui M, Yoshino S, Sakamoto K, Oka M.
    Gan To Kagaku Ryoho; 2009 Nov 28; 36(12):2351-3. PubMed ID: 20037419
    [Abstract] [Full Text] [Related]

  • 30. Surgical intervention for imatinib and sunitinib-resistant gastrointestinal stromal tumors.
    Kikuchi H, Setoguchi T, Miyazaki S, Yamamoto M, Ohta M, Kamiya K, Sakaguchi T, Konno H.
    Int J Clin Oncol; 2011 Dec 28; 16(6):741-5. PubMed ID: 21394667
    [Abstract] [Full Text] [Related]

  • 31. Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST.
    Kanda T, Masuzawa T, Hirai T, Ikawa O, Takagane A, Hata Y, Ojima H, Sodeyama H, Mochizuki I, Ishikawa T, Kagimura T, Nishida T.
    Jpn J Clin Oncol; 2017 Apr 01; 47(4):369-372. PubMed ID: 28073945
    [Abstract] [Full Text] [Related]

  • 32. Synchronous Large Gastrointestinal Stromal Tumor and Adenocarcinoma in the Stomach Treated with Imatinib Mesylate Followed by Total Gastrectomy.
    Namikawa T, Munekage E, Munekage M, Maeda M, Yatabe T, Kitagawa H, Sakamoto K, Obatake M, Kobayashi M, Hanazaki K.
    Anticancer Res; 2016 Apr 01; 36(4):1855-9. PubMed ID: 27069170
    [Abstract] [Full Text] [Related]

  • 33. Long-term adjuvant imatinib treatment for a patient who underwent complete resection of a localized recurrent gastrointestinal stromal tumor after preoperative imatinib treatment: A case report.
    Tjhoi WEH, Li K, Shou CH, Yang WL, Yu JR.
    Medicine (Baltimore); 2019 Feb 01; 98(6):e14477. PubMed ID: 30732216
    [Abstract] [Full Text] [Related]

  • 34. [A case of liver and bone metastasis from gastrointestinal stromal tumor treated using imatinib].
    Murakami M, Ebisui C, Okada K, Okamura S, Murata K, Nakagomi N, Tamai M, Kinuta M.
    Gan To Kagaku Ryoho; 2014 Jan 01; 41(1):99-101. PubMed ID: 24423961
    [Abstract] [Full Text] [Related]

  • 35. Adjuvant imatinib treatment in gastrointestinal stromal tumor: which risk stratification criteria and for how long? A case report.
    Blay JY, Levard A.
    Anticancer Drugs; 2016 Jan 01; 27(1):71-5. PubMed ID: 26457546
    [Abstract] [Full Text] [Related]

  • 36. [A case of multiple liver metastases after resection of gastrointestinal stromal tumor of the small intestine that was successfully treated with imatinib mesylate].
    Ebisui C, Okada K, Wada Y, Kato R, Makino S, Nishigaki T, Owada Y, Yanagisawa T, Okamura S, Fukuchi N, Murata K, Yokouchi H, Tamai M, Kinuta M.
    Gan To Kagaku Ryoho; 2013 Nov 01; 40(12):1708-10. PubMed ID: 24393896
    [Abstract] [Full Text] [Related]

  • 37. Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.
    Lin JX, Chen QF, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang CM.
    J Cancer Res Clin Oncol; 2017 Apr 01; 143(4):727-734. PubMed ID: 28083710
    [Abstract] [Full Text] [Related]

  • 38. [A Case of GIST of Stomach with Peritoneal Dissemination-Long-Term Survival with Imatinib and Surgical Resection].
    Nakata K, Masuzawa T, Katsuyama S, Sugimura K, Ikeshima R, Kawai K, Hiraki M, Shinke G, Katsura Y, Ohmura Y, Hata T, Takeda Y, Murata K.
    Gan To Kagaku Ryoho; 2022 Dec 01; 49(13):1429-1430. PubMed ID: 36733091
    [Abstract] [Full Text] [Related]

  • 39. Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study.
    Qi J, Liu HL, Ren F, Liu S, Shi W, Liu WH, Cai GQ, Liao GQ.
    World J Surg Oncol; 2020 Apr 07; 18(1):70. PubMed ID: 32264886
    [Abstract] [Full Text] [Related]

  • 40. Effect of loss of heterozygosity of the c-kit gene on prognosis after hepatectomy for metastatic liver gastrointestinal stromal tumors.
    Kikuchi H, Yamamoto M, Hiramatsu Y, Baba M, Ohta M, Kamiya K, Tanaka T, Suzuki S, Sugimura H, Kitagawa M, Kanai T, Kitayama Y, Kanda T, Nishikura K, Konno H.
    Cancer Sci; 2007 Nov 07; 98(11):1734-9. PubMed ID: 17894554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.